Nagler A - Search Results

1

Activity and tolerability of nilotinib: a retrospective multicenter analysis of chronic myeloid leukemia patients who are imatinib resistant or intolerant.

Koren-Michowitz M, le Coutre P, Duyster J, Scheid C, Panayiotidis P, Prejzner W, Rowe JM, Schwarz M, Goldschmidt N, Nagler A. Koren-Michowitz M, et al. Among authors: nagler a. Cancer. 2010 Oct 1;116(19):4564-72. doi: 10.1002/cncr.25351. Cancer. 2010. PMID: 20572041 Free article.

2

Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice.

Shimoni A, Nagler A. Shimoni A, et al. Among authors: nagler a. Cancer Treat Res. 2002;110:113-36. doi: 10.1007/978-1-4615-0919-6_6. Cancer Treat Res. 2002. PMID: 11908195 Review.

3

Assessment of the response to imatinib in chronic myeloid leukemia patients--comparison between the FISH, multiplex and RT-PCR methods.

Raanani P, Ben-Bassat I, Gan S, Trakhtenbrot L, Mark Z, Ashur-Fabian O, Itskovich S, Brok-Simoni F, Rechavi G, Amariglio N, Nagler A. Raanani P, et al. Among authors: nagler a. Eur J Haematol. 2004 Oct;73(4):243-50. doi: 10.1111/j.1600-0609.2004.00287.x. Eur J Haematol. 2004. PMID: 15347310

4

Apaf1 in chronic myelogenous leukemia (CML) progression: reduced Apaf1 expression is correlated with a H179R p53 mutation during clinical blast crisis.

Ashur-Fabian O, Adamsky K, Trakhtenbrot L, Cohen Y, Raanani P, Hardan I, Nagler A, Rechavi G, Amariglio N. Ashur-Fabian O, et al. Among authors: nagler a. Cell Cycle. 2007 Mar 1;6(5):589-94. doi: 10.4161/cc.6.5.3900. Epub 2007 Mar 23. Cell Cycle. 2007. PMID: 17361096

5

Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis.

Koren-Michowitz M, Hardan I, Berghoff J, Yshoev G, Amariglio N, Rechavi G, Nagler A, Trakhtenbrot L. Koren-Michowitz M, et al. Among authors: nagler a. Cancer Lett. 2007 Oct 8;255(2):307-14. doi: 10.1016/j.canlet.2007.05.005. Epub 2007 Jun 27. Cancer Lett. 2007. PMID: 17590504

6

A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD).

Koren-Michowitz M, Shimoni A, Vivante A, Trakhtenbrot L, Rechavi G, Amariglio N, Loewenthal R, Nagler A, Cohen Y. Koren-Michowitz M, et al. Among authors: nagler a. Leuk Res. 2008 Mar;32(3):421-7. doi: 10.1016/j.leukres.2007.07.003. Epub 2007 Aug 14. Leuk Res. 2008. PMID: 17698191

7

Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.

Sonneveld P, Hajek R, Nagler A, Spencer A, Bladé J, Robak T, Zhuang SH, Harousseau JL, Orlowski RZ; DOXIL-MMY-3001 Study Investigators. Sonneveld P, et al. Among authors: nagler a. Cancer. 2008 Apr 1;112(7):1529-37. doi: 10.1002/cncr.23326. Cancer. 2008. PMID: 18300257 Free article. Clinical Trial.

8

Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia.

Simanovsky M, Berlinsky S, Sinai P, Leiba M, Nagler A, Galski H. Simanovsky M, et al. Among authors: nagler a. Differentiation. 2008 Oct;76(8):908-22. doi: 10.1111/j.1432-0436.2008.00270.x. Epub 2008 Apr 29. Differentiation. 2008. PMID: 18452548

9

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies.

Berger R, Rotem-Yehudar R, Slama G, Landes S, Kneller A, Leiba M, Koren-Michowitz M, Shimoni A, Nagler A. Berger R, et al. Among authors: nagler a. Clin Cancer Res. 2008 May 15;14(10):3044-51. doi: 10.1158/1078-0432.CCR-07-4079. Clin Cancer Res. 2008. PMID: 18483370 Clinical Trial.

10

Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.

Baccarani M, Rosti G, Castagnetti F, Haznedaroglu I, Porkka K, Abruzzese E, Alimena G, Ehrencrona H, Hjorth-Hansen H, Kairisto V, Levato L, Martinelli G, Nagler A, Lanng Nielsen J, Ozbek U, Palandri F, Palmieri F, Pane F, Rege-Cambrin G, Russo D, Specchia G, Testoni N, Weiss-Bjerrum O, Saglio G, Simonsson B. Baccarani M, et al. Among authors: nagler a. Blood. 2009 May 7;113(19):4497-504. doi: 10.1182/blood-2008-12-191254. Epub 2009 Mar 4. Blood. 2009. PMID: 19264678 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,431 results

Search Page